Mark C. Schneyer, EVP, CFO: Acadia Pharmaceuticals ACAD Sell · Filed 24/11/19

Trade details

Type: Insider sale
Amount: $172,453.79
Shares · price: 10,259 sh · $16.81 a share
Held after: 53,302 sh
Stock: Acadia Pharmaceuticals ACAD
Person: Mark C. SchneyerEVP, CFO
Trade date: 24/11/19
Filed: 24/11/19
Days to filing: 0 days

Sold 16.1% of holdings

Share of holding sold: 16.1%

Acadia Pharmaceuticals trades, last 26 weeks

What else happened in Acadia Pharmaceuticals around then

Filed or reported within 30 days of the trade day · 24/10/20~24/12/19

Mark C. Schneyer's recent trades

Mark C. SchneyerEVP, CFO
Planned sale10b5-1 planAcadia Pharmaceuticals
Planned sale10b5-1 plan
Acadia Pharmaceuticals
ACAD
$158.8K
5,849 sh
$158.8K
Filed 08/05
Traded 08/05
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$76.4K
3,506 sh
$76.4K
Filed 05/05
Traded 05/04
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$60.1K
2,709 sh
$60.1K
Filed 04/07
Traded 04/07
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$89.7K
4,177 sh
$89.7K
Filed 03/26
Traded 03/25
Mark C. SchneyerEVP, CFO
SellAcadia Pharmaceuticals
Sell
Acadia Pharmaceuticals
ACAD
$68.7K
3,171 sh
$68.7K
Filed 03/26
Traded 03/26

Mark C. Schneyer, CFO — sold $172.5K of Acadia Pharmaceuticals ACAD · 16.1% of holdings | Whalegun